Cargando…

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

Patients with kidney failure have notoriously weak responses to common vaccines. Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in patients with chronic dialysis, we analyzed the humoral and T-cell response aft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrezenmeier, Eva, Bergfeld, Leon, Hillus, David, Lippert, Joerg-Detlev, Weber, Ulrike, Tober-Lau, Pinkus, Landgraf, Irmgard, Schwarz, Tatjana, Kappert, Kai, Stefanski, Ana-Luisa, Sattler, Arne, Kotsch, Katja, Dörner, Thomas, Sander, Leif Erik, Budde, Klemens, Halleck, Fabian, Kurth, Florian, Corman, Victor Max, Choi, Mira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284337/ https://www.ncbi.nlm.nih.gov/pubmed/34276681 http://dx.doi.org/10.3389/fimmu.2021.690698

Ejemplares similares

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany
por: Schwarz, Tatjana, et al.
Publicado: (2021)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
por: Mühlemann, Barbara, et al.
Publicado: (2021)

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center
por: Choi, Mira, et al.
Publicado: (2020)

Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
por: Lingscheid, Tilman, et al.
Publicado: (2022)

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
por: Hillus, David, et al.
Publicado: (2021)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
por: Duerr, Michael, et al.
Publicado: (2019)

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
por: Thibeault, Charlotte, et al.
Publicado: (2023)

Correction to: The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

De-novo malignancies after kidney transplantation: A long-term observational study
por: Fröhlich, Felix A., et al.
Publicado: (2020)

Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions
por: Wu, Kaiyin, et al.
Publicado: (2022)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Monkeypox in-patients with severe anal pain
por: Pfäfflin, Frieder, et al.
Publicado: (2022)

Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
por: Ronicke, Simon, et al.
Publicado: (2022)

A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
por: Mayrdorfer, Manuel, et al.
Publicado: (2022)

Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021)

Extended Criteria Donors in Living Kidney Transplantation Including Donor Age, Smoking, Hypertension and BMI
por: Plage, Henning, et al.
Publicado: (2020)

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
por: Frommert, Leonie Maria, et al.
Publicado: (2022)

Tozinameran+riltozinameran and tozinameran+famtozinameran for prevention of COVID-19
Publicado: (2023)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022)

Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis
por: Lingscheid, Tilman, et al.
Publicado: (2022)

Influence of lipid profile and statin administration on arterial stiffness in renal transplant recipients
por: Heleniak, Zbigniew T., et al.
Publicado: (2022)

COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
por: Mikhailov, Michael, et al.
Publicado: (2023)

Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney Donors
por: El-Bandar, Nasrin, et al.
Publicado: (2022)

SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
por: Gruell, Henning, et al.
Publicado: (2022)

The human host response to monkeypox infection: a proteomic case series study
por: Wang, Ziyue, et al.
Publicado: (2022)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Tozinameran: Acute myocarditis
Publicado: (2021)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bojj8a4m31dd0lq3cvaj1hoieq